Breaking News Instant updates and real-time market news.

UNVR

Univar

$22.42

(0.00%)

09:45
04/18/19
04/18
09:45
04/18/19
09:45

Univar reinstated with a Neutral at Goldman Sachs

Goldman Sachs analyst Robert Koort reinstated Univar with a Neutral and $25 price target saying the Nexeo integration opportunity is balanced by subdued end markets.

  • 08

    May

  • 09

    May

UNVR Univar
$22.42

(0.00%)

11/27/18
JEFF
11/27/18
NO CHANGE
Target $28
JEFF
Buy
Jefferies lays out case for Univar shares doubling by end of 2020
Jefferies analyst Laurence Alexander estimates the combined Univar (UNVR) and Nexeo Solutions (NXEO) could achieve $2.70 of earnings per share by 2021 even in a "choppy" environment, with $5.65 per share of cumulative free cash flow over the next two years. A double in the share price by the end of 2020 to $44 per share would hinge on a Plastics divestiture, free cash flow and proceeds deployed to less than three-times net debt to EBITDA, and a stronger conversion ratio, lifting the multiple to 8.5 times EBITDA, 16.1 times earnings and a 6.5% free cash flow yield, Alexander tells investors in a research note. With the deal scheduled to close in the first half of 2019, the analyst does not expect a detailed update on synergies until early 2020. However, he sees "significant" potential upside to estimates and keeps a Buy rating on Univar. The analyst lowered his price target for the stock to $28 from $33.
01/03/19
VERT
01/03/19
UPGRADE
VERT
Buy
Univar upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Kevin McCarthy upgraded Univar (UNVR) to Buy from Hold, citing his view that the deal to combine with Nexeo Solutions (NXEO) amplifies its growth, not its risk.
03/05/19
WELS
03/05/19
NO CHANGE
Target $30
WELS
Outperform
Univar price target raised to $30 from $25 at Wells Fargo
Wells Fargo analyst Allison Poliniak-Cusic raised her price target for Univar to $30 from $25 following updated guidance. The analyst reiterates an Outperform rating on the shares.
04/17/19
BREN
04/17/19
DOWNGRADE
BREN
Hold
Univar downgraded to Hold from Buy at Berenberg

TODAY'S FREE FLY STORIES

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:31
12/12/19
12/12
18:31
12/12/19
18:31
Hot Stocks
Breaking Hot Stocks news story on Sarepta »

Sarepta to resume trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

18:25
12/12/19
12/12
18:25
12/12/19
18:25
Hot Stocks
Adobe CEO: We are not overly concerned with the trade war with China »

Comment from interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:20
12/12/19
12/12
18:20
12/12/19
18:20
Hot Stocks
Sarepta announces FDA approval of VYONDYS 53 injection to treat DMD »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,760.44

11.33 (0.65%)

18:11
12/12/19
12/12
18:11
12/12/19
18:11
Hot Stocks
Amazon orders fourth season of 'The Marvelous Mrs. Maisel' »

Amazon Studios announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHAI

OHA Investment

$1.28

(0.00%)

, PTMN

Portman Ridge Finance

$2.04

(0.00%)

18:10
12/12/19
12/12
18:10
12/12/19
18:10
Hot Stocks
OHA Investment obtains stockholder approval of Portman Ridge deal »

OHA Investment…

OHAI

OHA Investment

$1.28

(0.00%)

PTMN

Portman Ridge Finance

$2.04

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCT

Oncternal Therapeutics

$4.62

0.05 (1.09%)

18:05
12/12/19
12/12
18:05
12/12/19
18:05
Hot Stocks
Oncternal presents interim data from Phase 1b clinical study of cirmtuzumab »

Oncternal Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZN

Horizon Global

$3.49

0.14 (4.18%)

18:03
12/12/19
12/12
18:03
12/12/19
18:03
Hot Stocks
Horizon Global CFO Jamie Pierson steps down »

Horizon Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

18:03
12/12/19
12/12
18:03
12/12/19
18:03
Hot Stocks
Oracle CEO Catz says expects momentum in 2H20 to carry into FY21 »

Says feels "very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:00
12/12/19
12/12
18:00
12/12/19
18:00
Hot Stocks
Breaking Hot Stocks news story on Sarepta »

Sarepta trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

17:52
12/12/19
12/12
17:52
12/12/19
17:52
Hot Stocks
Oracle's Ellison says 'we have no plans for having a second CEO' »

Says there won't be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

, EVRC

Evercel, Inc

$0.00

(0.00%)

17:41
12/12/19
12/12
17:41
12/12/19
17:41
Hot Stocks
NewLink Genetics advances over 11% after Evercel discloses rejected offer »

Shares of NewLink…

NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

EVRC

Evercel, Inc

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRC

Evercel, Inc

$0.00

(0.00%)

, NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

17:36
12/12/19
12/12
17:36
12/12/19
17:36
Hot Stocks
Evercel announces rejected offer to acquire NewLink Genetics »

Evercel (EVRC) has made…

EVRC

Evercel, Inc

$0.00

(0.00%)

NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.30

0.225 (3.70%)

17:34
12/12/19
12/12
17:34
12/12/19
17:34
Hot Stocks
Corsair Capital reports 8.77% passive stake in Baudax Bio »

Corsair Capital disclosed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

GVA

Granite Construction

$27.55

1.255 (4.77%)

17:33
12/12/19
12/12
17:33
12/12/19
17:33
Hot Stocks
Granite Construction subsidiary awarded $16M contract to rehabilitate I-94 »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$71.58

-0.195 (-0.27%)

17:29
12/12/19
12/12
17:29
12/12/19
17:29
Syndicate
Breaking Syndicate news story on Envestnet »

Envestnet files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$224.48

-8.83 (-3.78%)

17:28
12/12/19
12/12
17:28
12/12/19
17:28
Syndicate
Lululemon holder Advent said to offer 2.6M shares, Bloomberg reports »

Block offer range seen at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

17:26
12/12/19
12/12
17:26
12/12/19
17:26
Hot Stocks
Oracle sees FY20 CapEx approximately $2.2B »

Sees FY20 tax rate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

17:25
12/12/19
12/12
17:25
12/12/19
17:25
Earnings
Oracle sees 'double digit' EPS growth in FY20, consensus $3.88 »

Sees FY20 revenue growing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

17:25
12/12/19
12/12
17:25
12/12/19
17:25
Conference/Events
Washington Association of Money Managers to hold a panel discussion »

The Washington…

ORCL

Oracle

$56.47

0.16 (0.28%)

17:24
12/12/19
12/12
17:24
12/12/19
17:24
Earnings
Oracle sees Q3 adjusted EPS 96c-98c, consensus 97c »

Guidance in constant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NPO

EnPro

$66.48

2.53 (3.96%)

17:22
12/12/19
12/12
17:22
12/12/19
17:22
Hot Stocks
EnPro company acquired by Arcline for $450M »

Arcline Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

17:21
12/12/19
12/12
17:21
12/12/19
17:21
Hot Stocks
Oracle says Q2 'another solid quarter' »

Says: Expects revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NXPI

NXP Semiconductors

$123.98

2.54 (2.09%)

17:19
12/12/19
12/12
17:19
12/12/19
17:19
Hot Stocks
NXP Semiconductors director sells 13.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

PFE

Pfizer

$38.54

0.3 (0.78%)

17:13
12/12/19
12/12
17:13
12/12/19
17:13
Hot Stocks
Pfizer says FDA approves XELJANZ XR tablets for treatment of UC »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELS

Equity Lifestyle

$69.93

-1.13 (-1.59%)

17:12
12/12/19
12/12
17:12
12/12/19
17:12
Hot Stocks
Equity Lifestyle COO sells 18K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.